Contact Information: For more information, contact: Lauren Pearson C: (224) 374-8610 O: (847) 384-4031 Catherine Dolf C: (847) 894-9112 O: (847) 384-4034
The 21st Century Triple Play
What Is Next in Stem Cells, Tissue Engineering and Gene Therapy?
| Source: AAOS
SAN FRANCISCO, CA--(Marketwire - March 5, 2008) - The use of stem cells may
have the power to transform orthopaedic surgery now and in the future.
These "undifferentiated, unspecialized cells" already exist in our bodies
and can renew themselves, giving rise to one or more specialized cells that
have specific functions within the body. The use of stem cells is a
biotechnology that is developing rapidly, offering new hope to patients
suffering from musculoskeletal conditions.
Over the past few years, orthopaedic surgeons have successfully used
patients' own stem cells to reverse very painful, disabling conditions.
Just last year, Thomas Einhorn, MD, chairman of the Department of
Orthopaedic Surgery and professor of Orthopaedic Surgery, Biochemistry and
Biomedical Engineering at Boston University, performed his first revision
hip replacement surgery using the new technology of harvesting his
patient's own stem cells.
"This area of musculoskeletal medicine shows great promise for the use of
stem cells, tissue engineering and gene therapy," Dr. Einhorn stated. "As
orthopaedic scientists, researchers and surgeons, we treat bones, joints,
tissues and muscles -- the exact areas where stem cells are meant to be put
to use."
Adult stem cells are readily available from a number of sources -- from fat
harvested through liposuction to muscle tissue and bone marrow biopsies.
Today, stem cell technology is being used for fracture repair and bony
defects. However, the implications for the not-so-distant future are
beyond the imagination.
In 2005, nearly 25 million people visited their physician due to arthritis,
according to the American Academy of
Orthopaedic Surgeons (AAOS).
"Arthritic patients come into our offices and ask what we can do for them,"
Dr. Einhorn continued. "One day soon, we may be able to harvest their
body's own stem cells and direct those cells to the damaged and
degenerative cartilage, which causes the arthritic pain. This application
may restore and regenerate the cartilage to a normal state. Stem cells
have the power to become the cells that your body has lost or needs."
Orthopaedic research scientists are working on stem cell therapies to
improve:
-- tissue healing
-- muscle regeneration
-- cartilage repair and bone growth
-- orthopaedic diseases and conditions (including osteoarthritis, osteoporosis, osteosarcomas and even muscular
dystrophy)
Stem cells could eventually eliminate the need for joint
replacement as researchers find ways for cartilage and bone to
regenerate in specific areas.
Orthopaedic trauma -- including fracture repair and failure of bone healing
-- represents a significant burden of disease. Patients suffering from
orthopaedic trauma may be the greatest beneficiaries of many futuristic
cell harvesting techniques. In fact, each year, trauma-related orthopaedic
conditions account for 1.9 million hospitalizations and over $30 billion in
total charges.
Dr. Einhorn will moderate the ins and outs of this newer technology and
what it means to the field of musculoskeletal medicine at a media briefing
entitled "The 21st Century Triple Play: Stem Cells, Tissue Engineering and
Gene Therapy." The briefing occurs on Wednesday, Mar. 5, 2008, at the 75th
Annual Meeting of the American Academy of
Orthopaedic Surgeons (AAOS) in the Moscone Convention Center, South
Mezzanine, at 9:00 a.m., in Room 224.
Panelists scheduled to join Dr. Einhorn: Johnny Huard, PhD, Scott Boden,
MD, and Scott Rodeo, MD. Dr. Huard, a cutting-edge researcher at the
University of Pittsburg, will discuss the relationship between stem cells
and gene therapy and Dr. Boden, the application of this futuristic medicine
as it relates to the spine and other bone applications, while Dr. Rodeo
will discuss stem cells and their use for soft tissues, including muscles
and tendons, and future implications for musculoskeletal medicine.
Orthopaedic Research Society (ORS)
About
AAOS